BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17645686)

  • 1. Regarding probabilistic analysis and computationally expensive models: necessary and required?
    Caro JJ; Getsios D; Möller J
    Value Health; 2007; 10(4):317-8; author reply 319. PubMed ID: 17645686
    [No Abstract]   [Full Text] [Related]  

  • 2. Probabilistic analysis and computationally expensive models: Necessary and required?
    Griffin S; Claxton K; Hawkins N; Sculpher M
    Value Health; 2006; 9(4):244-52. PubMed ID: 16903994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness acceptability curves--caveats quantified.
    Jakubczyk M; Kamiński B
    Health Econ; 2010 Aug; 19(8):955-63. PubMed ID: 19688780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uncertainty in cost-effectiveness analysis. Probabilistic uncertainty analysis and stochastic league tables.
    Baltussen RM; Hutubessy RC; Evans DB; Murray CJ
    Int J Technol Assess Health Care; 2002; 18(1):112-9. PubMed ID: 11987434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost estimates and uncertainty: the expected value technique.
    Hosp Cost Manag Account; 1992 May; 4(2):1-8. PubMed ID: 10117914
    [No Abstract]   [Full Text] [Related]  

  • 6. Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra.
    Claxton K; Sculpher M; McCabe C; Briggs A; Akehurst R; Buxton M; Brazier J; O'Hagan T
    Health Econ; 2005 Apr; 14(4):339-47. PubMed ID: 15736142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of instrumental variables: an alternative to traditional modeling?
    Neyt M; Van Brabandt H; De Laet C
    Value Health; 2011 Jan; 14(1):1-2. PubMed ID: 21211480
    [No Abstract]   [Full Text] [Related]  

  • 8. Handling uncertainty of the economic evaluation result: sensitivity analysis.
    Limwattananon S
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S59-65. PubMed ID: 19253488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An introduction to the methods of cost-effectiveness analysis.
    Drug Ther Bull; 2012 Jul; 50(7):81-4. PubMed ID: 22789768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expected value of information and decision making in HTA.
    Eckermann S; Willan AR
    Health Econ; 2007 Feb; 16(2):195-209. PubMed ID: 16981193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of clinical effects.
    Teerawattananon Y; Thavorncharoensap M; Mohara A
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S38-42. PubMed ID: 19253486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling the value for money of changing clinical practice change: a stochastic application in diabetes care.
    Hoomans T; Abrams KR; Ament AJ; Evers SM; Severens JL
    Med Care; 2009 Oct; 47(10):1053-61. PubMed ID: 19648827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health technology assessment in the cost-disutility plane.
    Eckermann S; Briggs A; Willan AR
    Med Decis Making; 2008; 28(2):172-81. PubMed ID: 18356312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis and innovation.
    Jena AB; Philipson TJ
    J Health Econ; 2008 Sep; 27(5):1224-36. PubMed ID: 18619695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies.
    Claxton K
    J Health Econ; 1999 Jun; 18(3):341-64. PubMed ID: 10537899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost/benefit analysis-another dimension.
    Hess OW
    Med Instrum; 1982; 16(1):76-7. PubMed ID: 6801445
    [No Abstract]   [Full Text] [Related]  

  • 17. Technology assessment in the German context.
    Drummond M
    Eur J Health Econ; 2007 Sep; 8 Suppl 1():S3. PubMed ID: 17619919
    [No Abstract]   [Full Text] [Related]  

  • 18. Need for speed: an efficient algorithm for calculation of single-parameter expected value of partial perfect information.
    Sadatsafavi M; Bansback N; Zafari Z; Najafzadeh M; Marra C
    Value Health; 2013; 16(2):438-48. PubMed ID: 23538197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ten arguments for a societal perspective in the economic evaluation of medical innovations.
    Jönsson B
    Eur J Health Econ; 2009 Oct; 10(4):357-9. PubMed ID: 19618224
    [No Abstract]   [Full Text] [Related]  

  • 20. Technology assessment and the doctor-patient relationship.
    Wax AL
    Va Law Rev; 1996 Nov; 82(8):1641-62. PubMed ID: 16715567
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.